Vitamin K2-7 decreases arterial stiffness (cleans arteries) – RCT
Menaquinone-7 supplementation improves arterial stiffness in healthy postmenopausal women: double-blind randomised clinical trial
Thrombosis and Haemostasis, DOI: http://dx.doi.org/10.1160/TH14-08-0675
M. H. J. Knapen (1), L. A. J. L. M. Braam (1), N. E. Drummen (1), O. Bekers (2), A. P. G. Hoeks (3), C. Vermeer (1)
(1) VitaK & Cardiovascular Research Institute (CARIM), Maastricht University, The Netherlands; (2) Central Diagnostic Laboratory, University Hospital Maastricht, The Netherlands; (3) Biomedical Engineering, Maastricht University, The Netherlands
Observational data suggest a link between menaquinone (MK, vitamin K2) intake and cardiovascular (CV) health. However, MK intervention trials with vascular endpoints are lacking. We investigated long-term effects of MK-7 ( 180 µg MenaQ7/day) supplementation on arterial stiffness in a double-blind, placebo-controlled trial. Healthy postmenopausal women (n=244) received either placebo (n=124) or MK-7 (n=120) for three years . Indices of local carotid stiffness (intima-media thickness IMT, Diameter end-diastole and Distension) were measured by echotracking. Regional aortic stiffness (carotid-femoral and carotid-radial Pulse Wave Velocity, cfPWV and crPWV, respectively) was measured using mechanotransducers. Circulating desphospho-uncarboxylated matrix Gla-protein (dp-ucMGP) as well as acute phase markers Interleukin-6 (IL-6), high-sensitive C-reactive protein (hsCRP), tumour necrosis factor-α (TNF-α) and markers for endothelial dysfunction Vascular Cell Adhesion Molecule (VCAM), E-selectin, and Advanced Glycation Endproducts (AGEs) were measured. At baseline dp-ucMGP was associated with IMT, Diameter, cfPWV and with the mean z-scores of acute phase markers (APMscore) and of markers for endothelial dysfunction (EDFscore).
After three year MK-7 supplementation
cfPWV and the Stiffness Index β significantly decreased in the total group, whereas
distension,
compliance,
distensibility,
Young’s Modulus, and the
local carotid PWV (cPWV)
improved in women having a baseline Stiffness Index β above the median of 10.8.
MK-7 decreased dp-ucMGP by 50 % compared to placebo, but did not influence the markers for acute phase and endothelial dysfunction.
In conclusion, long-term use of MK-7 supplements improves arterial stiffness in healthy postmenopausal women, especially in women having a high arterial stiffness.

Download the PDF from VitaminDWiki
See also Google Scholar
Google Scholar has links to 234 papers citing this study as of July 2023
Vitamin K2—a neglected player in cardiovascular health: a narrative review - Nov 2021 FREE PDF
Vitamin K2 and D in Patients With Aortic Valve Calcification: A Randomized Double-Blinded Clinical Trial - April 2022 10.1161/CIRCULATIONAHA.121.053708 FREE PDF
- 720 µg MK-7 plus 25 µg vitamin D for 24 months did not help those with severe plaque
Menaquinone-7 Supplementation to Reduce Vascular Calcification in Patients with Coronary Artery Disease: Rationale and Study Protocol (VitaK-CAC Trial) 2015, full text online, no publication of that trial as of Aug 2017
Crosstalk between Vitamins A, B12, D, K, C, and E Status and Arterial Stiffness 2017, full text online
See also VitaminDWiki
Hypothesis: Vitamin K will reduce prostate blood vessel problems – Jan 2015
Interview of Vitamin K2 and Calcium Paradox author by Dr. Mercola – Dec 2012
Overview Vitamin K and Vitamin D many items by Vermeer, who co-authored this paper
Items in both categories Cardiovascular and Vitamin K
{category}
Items in both categories Bones and Vitamin K
{category}
See also Life Extension Magazine Nov 2017
Download "Vitamin K Reverses Arterial Stiffness" from VitaminDWiki
has 62 references
See also web
Arterial Stiffness Index and Coronary Artery Plaques in Patients with Subclinical Coronary Atherosclerosis - Jan 2015 - doi: 10.6515/ACS20140630B FREE PDF
Chronic plaque psoriasis is associated with increased arterial stiffness - 2009
short url = is.gd/K2CalciumRCT
